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CREB3L1/OASIS is a cellular transcription factor
synthesized as a membrane-bound precursor and
activated by regulated intramembrane proteolysis in
response to stimuli like ER stress. Comparing gene
expression between Huh7 subclones that are per-
missive for hepatitis C virus (HCV) replication versus
the nonpermissive parental Huh7 cells, we identified
CREB3L1 as a host factor that inhibits proliferation
of virus-infected cells. Upon infection with diverse
DNA and RNA viruses, including murine g-herpes-
virus 68, HCV, West Nile virus (WNV), and Sendai
virus, CREB3L1 was proteolytically cleaved, allowing
its NH2 terminus to enter the nucleus and induce
multiple genes encoding inhibitors of the cell cycle
to block cell proliferation. Consistent with this, we
observed a necessity for CREB3L1 expression to be
silenced in proliferating cells that harbor replicons
of HCV or WNV. Our results indicate that CREB3L1
may play an important role in limiting virus spread
by inhibiting proliferation of virus-infected cells.
INTRODUCTION
Hepatitis C virus (HCV), a positive-stranded RNA virus within the
family Flaviviridae, accounts for most cases of chronic liver
disease (Appel et al., 2006;Moradpour et al., 2007). In pioneering
studies of HCV replication in cultured cells, Lohmann et al. trans-
fectedHuh7 cellswith anHCV subgenomic replicon that consists
of HCV RNA engineered to express a selectable marker gene,
neo, in place of a portion of the viral RNA that is not required for
viral replication (Lohmann et al., 1999). Following selection with
G418, subclones of Huh7 cells were established in which HCV
RNA was constantly replicating and producing viral proteins
required for its replication, such as NS5A (Lohmann et al.,
1999). However, only a few cells survived the selection, an obser-
vation suggesting that Huh7 cells are not permissive for HCV
replication (Lohmann et al., 1999; Blight et al., 2002). Subse-
quently, Blight et al. observed that when HCV RNA was elimi-
nated from the cells harboring the HCV replicon through inter-
feron treatment, the cured cells showed dramatically enhancedCpermissiveness for HCV RNA replication, as demonstrated by
the large number of cells that survived G418 selection following
retransfection with the HCV replicon RNA (Blight et al., 2002).
The best-characterized line of these cells is Huh7.5 cells (Blight
et al., 2002). By comparing the difference between Huh7 cells
and Huh7.5 cells, Sumpter et al. observed that, unlike parental
Huh7 cells, Huh7.5 cells failed to produce type 1 interferon in
response to viral infection, as a result of a dominant negative
mutation in the RIG-I gene (Sumpter et al., 2005). These studies
suggest that comparing the difference between subclones of
Huh7 cells that are permissive for HCV replication versus their
nonpermissive parental Huh7 cells could be a powerful approach
to identify cellular proteins that defend against viral infection.
In the current study, we identify cAMP response element-
binding protein 3-like 1 (CREB3L1, also known as OASIS) as
a cellular transcription factor expressed in parental Huh7 cells,
but not in Huh7.5 cells and another subclone of Huh7 cells that
are different from Huh7.5 cells but also highly permissive for
HCV replication. CREB3L1 belongs to a family of transcription
factors that are synthesized as membrane-bound precursors in
the endoplasmic reticulum (ER). In response to stimulation, the
protein is transported to the Golgi, where they are activated
through regulated intramembrane proteolysis (RIP) (Brown
et al., 2000;Murakami et al., 2006). RIP consists of two sequential
cleavagesmediated bySite-1 protease (S1P) andSite-2 protease
(S2P).TheS1P-catalyzedcleavageat the lumenal side is aprereq-
uisite for the S2P-catalyzed intramembrane cleavage that
releases the NH2-terminal domain of the protein from mem-
branes, allowing it to drive transcription of target genes in the
nucleus (Brown et al., 2000). In osteoblasts, ER stress triggers
RIP of CREB3L1 by S1P and S2P, and the nuclear fragment
activates the gene encoding type 1 collagen (Murakami et al.,
2009). The function of CREB3L1 in other cells is unknown. Here,
we show that CREB3L1 is proteolytically activated in cells
infected by HCV or other RNA and DNA viruses to block prolifer-
ation of these cells by inducing transcription of genes encoding
inhibitors to thecell cycle.Asa result,CREB3L1has tobesilenced
in proliferating cells that support viral replication.RESULTS
CREB3L1 Inhibits HCV Replication
While themutation inRIG-I helps to render Huh7.5 more suscep-
tible to HCV infection, this mutation may not be sufficient toell Host & Microbe 10, 65–74, July 21, 2011 ª2011 Elsevier Inc. 65
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Figure 1. CREB3L1 Inhibits HCVReplication
(A) Real-time QPCR quantification of CREB3L1
mRNA in indicated cells with the value in Huh7
cells set to 1. (All panels) Bar graphs are reported
as mean ± SD (n = 3).
(B) Immunoblot analysis of CREB3L1 protein in
indicated cells.
(C and D) On day zero, Huh7 cells were seeded at
1 3 105/60 mm dish. On day one, they were
transfected with indicated siRNA (20 pmol/dish).
On day three, these cells were transfected with the
HCV replicon RNA (HP, 0.5 mg/dish). On day four,
the cells were harvested, and the amount of
CREB3L1 protein was determined by immunoblot
analysis (C). HCV RNA was quantified by real-time
QPCR, with the amount of HCV RNA in cells
treated with the control siRNA set to 1 (D).
(E) Huh7.5 cells were seeded and transfected with
indicated siRNA as described in (C). On day three,
the cells were infected with the JFH strain of HCV
virion. On day four, the cells were harvested, and
the amount of HCV RNA was quantified as
described in (C).
(F) On day zero, Huh7-K2040 cells were seeded at
7 3 105/60 mm dish. On day one, they were
transfected with 0.5 mg of a plasmid derived from
pTracer as indicated. On day two, the cells were
trypsinized and sorted through FACS based on
expression of GFP. Lysates of the cells with or
without GFP expression were subject to immu-
noblot analysis with indicated antibodies.
(G) Huh7.5 cells transfected with the indicated
plasmid were isolated from untransfected Huh7.5
cells based on GFP expression, as described in
(D), and seeded at 2 3 105/60 mm dish. They
were infected by the JFH strain of HCV virion 24 hr
later. Following incubation for 3 days, HCV RNA
in the cells was quantified by real-time QPCR, with
the value in cells transfected with the empty
pTracer set at 1.
Cell Host & Microbe
CREB3L1 Blocks Division of Virus-Infected Cellscause permissiveness for HCV replication. We found that
knockdown of RIG-I by RNAi did not enhance replication of
HCV in Huh7 cells (Figure S1A). A similar result was also
observed previously (Binder et al., 2007). Thus, it is likely that
Huh7.5 cells may have altered expression of other genes that
limit HCV replication. We sought to identify these genes by
comparative microarray analysis of Huh7 and Huh7.5 cells.
These experiments were inconclusive, due to the large number
of genes differentially expressed between these cells. To narrow
the candidate genes, we needed an independent line of Huh7
cells also permissive for HCV replication, so that we might iden-
tify genes with reduced expression in both lines of permissive
cells. For this purpose, we treated Huh7-K2040 cells, a line of
Huh7 cells that harbor an HCV replicon (Ye et al., 2003), with
interferon to obtain a clone of cured Huh7 cells that no longer
contained HCV RNA. HCV replicon RNA was then retransfected
into these cells to determine their permissiveness for HCV repli-
cation. Similar to Huh7.5 cells, these cells were more permissive
for HCV replication than their parental Huh7 cells, as measured
by the number of colonies that contain the HCV replicon encod-
ing the neo (Figure S1B) or by the activity of luciferase encoded
by an HCV replicon RNA that contains the luciferase sequence in
lieu of neo (Vrolijk et al., 2003) (Figure S1C). We named the cured66 Cell Host & Microbe 10, 65–74, July 21, 2011 ª2011 Elsevier Inc.Huh7-K2040 cells HCV replication-permissive (HRP)-1 cells.
Unlike Huh7.5 cells, HRP-1 cells do not contain a mutation in
RIG-I, and they were not defective in activating interferon-
induced genes after infection with Sendai virus (Figure S1D).
Microarray analysis revealed 26 genes whose expression was
reduced by more than 10-fold in both HRP-1 and Huh7.5 cells
compared to the parental Huh7 cells (Table S1). Among these
genes, we chose to focus on CREB3L1, because infection with
West Nile virus (WNV), another flavivirus, was known to reduce
the amount of this protein in neurons (van Marle et al., 2007).
Quantitative real-time PCR (real-time QPCR) analysis showed
that the expression of CREB3L1 was reduced by more than
10-fold in both Huh7.5 and HRP-1 compared to the parental
Huh7 cells (Figure 1A). Expression of CREB3L1 was also
reduced in Huh7-K2040 cells, the progenitor for HRP-1 cells
that harbors an HCV replicon (Figure 1A). Immunoblot analysis
confirmed the difference in the amount of CREB3L1 protein
among these cells (Figure 1B). We then determined whether
the lack of expression of CREB3L1 renders cells permissive for
HCV replication. CREB3L1 was markedly knocked down by
siRNAs targeting two different regions of CREB3L1 mRNA (Fig-
ure 1C). Treatment of Huh7 cells with these siRNAs raised the
amount of HCV replicon RNA replicated in the cells (Figure 1D).
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Figure 2. CREB3L1 Undergoes RIP in HCV-
Infected Cells
(A) Schematic diagram of CREB3L1.
(B and C) On day zero, indicated cells (B) or Huh7-
K2040 cells (C) were seeded at 4 3 105/60 mm
dish. On day one, theywere transfected with 50 ng
of indicated plasmids. On day two, the cells were
harvested and separated into nuclear and
membrane fractions followed by immunoblot
analysis with anti-HSV. Asterisk (*) denotes
a cross-reactive band. Immunoblots of calnexin
and Lysine-specific demethylase 1 (LSD1) served
as loading controls for membrane and nuclear
fractions, respectively.
(D and E) Huh7-K2040 cells transfected with the
indicated plasmid were analyzed as described in
Figure 1F.
Cell Host & Microbe
CREB3L1 Blocks Division of Virus-Infected CellsTo study the replication of live virus, we used the JFH strain of
HCV, the only strain of the virus that infects cultured cells (Wakita
et al., 2005). We used Huh7.5 instead of Huh7 or HRP-1 cells
because the latter cells were not infected by the virion, possibly
owing to their intact interferon responses. Although Huh7.5 cells
are already permissive for HCV replication and express less
CREB3L1 compared to Huh7 cells, knockdown of CREB3L1
by RNAi led to a further increase in HCV RNA after these cells
were infected by the HCV virion (Figure 1E).
To determine whether overexpression of CREB3L1 inhibits
HCV replication, we transfected CREB3L1 into Huh7-K2040
cells. Due to the problem of low transfection efficiency, we
subcloned CREB3L1 into a plasmid that also expresses GFP
(pTracer). We used a fluorescence-activated cell sorter (FACS)
to isolate cells that expressed GFP and CREB3L1 (Figure 1F,
lane 4). CREB3L1 displayed two bands as a result of proteolytic
cleavage (see below). The amount of NS5A, an HCV protein
whose expression depends on viral replication (Ye et al., 2003),
was markedly reduced in these cells (Figure 1F, lane 4). This
effect was not due to the expression of GFP because transfec-
tion of the empty pTracer encoding GFP, but not CREB3L1,
did not reduce the amount of NS5A (Figure 1F, lane 2). To deter-
mine the effect of CREB3L1 overexpression on infection of the
HCV virion, we transfected Huh7.5 cells with pTracer-CREB3L1
or the pTracer vector, isolated transfected cells through FACS,
and infected these cells with the HCV virion. As shown in Fig-
ure 1G, overexpression of CREB3L1 also reduced the amount
of HCV RNA in Huh7.5 cells infected by the HCV virion.Cell Host & Microbe 10, 6CREB3L1 Is Proteolytically
Activated in Cells Harboring
an HCV Replicon
CREB3L1 contains a recognition se-
quence for S1P (RXXL located within 30
residues from the transmembrane helix)
(Hua et al., 1996) and S2P (helix-breaking
sequences, such as PXXP, in the trans-
membrane helix) (Ye et al., 2000) (Fig-
ure 2A). To determine whether RIP
of CREB3L1 is induced in hepatoma
cells by HCV infection, we transfected
a plasmid encoding CREB3L1, taggedat the NH2 terminus with an epitope derived from herpes
simplex virus (HSV), into Huh7, HRP-1, and Huh7-K2040 cells.
The expression of CREB3L1 encoded by the plasmid was driven
by the weak thymidine kinase (TK) promoter to avoid constitu-
tive cleavage of the protein caused by excessive overexpres-
sion. The amount of full-length CREB3L1 and the NH2-terminal
fragment of CREB3L1 was detected by anti-HSV, which is
sensitive enough to detect transfected proteins driven by the
TK promoter in immunoblot analysis (Hua et al., 1996). In
Huh7 and HRP-1 cells, which do not contain an HCV replicon,
we observed only the full-length precursor of CREB3L1, with
a molecular weight of 80 kDa in the membrane fraction (Fig-
ure 2B, lanes 2 and 6). Cleaved CREB3L1 was not detectable
in the nuclear fraction (Figure 2B, lanes 2 and 6). In Huh7-
K2040 cells, which contain an HCV replicon, the cleaved
NH2-terminal fragment of CREB3L1 (nuclear form, 55 kDa)
was prominent in the nuclear fraction (Figure 2B, lane 4). In
these cells, generation of the nuclear form was reduced when
we transfected plasmids encoding CREB3L1 with mutations
that disrupt the consensus S1P (R423A) or S2P recognition
site (P392A/P395A) (Figure 2C, lanes 2–4). When the S2P
recognition site was altered, we observed in the membrane
fraction a cleaved fragment with a molecular weight similar
to the nuclear form (Figure 2C, lane 4). This fragment is the
membrane-bound intermediate form of CREB3L1 that is
cleaved by S1P, but not by S2P. A similar cleavage intermediate
was observed for SREBP-2, a prototype of RIP substrates,
when its S2P recognition site was disrupted (Ye et al., 2000).5–74, July 21, 2011 ª2011 Elsevier Inc. 67
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Figure 3. Nuclear Form of CREB3L1
Activates Genes that Inhibit the Cell Cycle
(A) Huh7-K2040 cells were seeded, transfected
with pTracer or pTracer-CREB3L1(D381–519) as
described in Figure 1D. The transfected cells were
isolated based on GFP expression as described in
Figure 1D. The amount of indicated mRNA was
quantified by real-time QPCR. Fold induction of
indicated mRNA by CREB3L1(D381–519) was
determined by setting the amount of the mRNA in
cells transfected with the control plasmid pTracer
at 1. Results are reported as mean ± SD (n = 3).
(B and D) On day zero, Huh7-K2040 cells were
seed at 73 105/60 mm dish. On day one, the cells
were transfected with a firefly luciferase reporter
plasmid containing the indicated region of p21
promoter (1 mg/dish) and a plasmid encoding
Renilla luciferase driven by the constitutive CMV
promoter (0.5 mg/dish) in the absence or presence
of cotransfection of pCMV-CREB3L1(D381–519)
(0.5 mg/dish). On day two, luciferase activity
was measured, and the promoter activity was
determined by firefly luciferase activity normalized
against Renilla luciferase activity to control for
transfection efficiency. Fold increase in the
promoter activity in cells transfected with
CREB3L1(D381–519) compared to those mock-
transfected was presented. Results are reported
as mean ± SD (n = 3).
(C) Alignment of 34 to 26 of the p21 promoter
region with promoter sequences from indicated
genes.
(E) On day zero, Huh7-K2040 cells were seeded at 2.53 105/60 mm dish. On day three, they were transfected with 0.5 mg of indicated plasmids. On day four, the
cells were harvested, and the cell lysate was immunoprecipitated with control IgG (C) or anti-FLAG IgG (Flg) followed by ChIP analysis, as described in
Experimental Procedures.
Cell Host & Microbe
CREB3L1 Blocks Division of Virus-Infected CellsThese results suggest that CREB3L1 is activated through RIP in
HCV-infected cells.
To determine whether production of the nuclear CREB3L1
is sufficient to inhibit HCV replication, we transfected Huh7-
K2040 cells with a plasmid encoding the truncated NH2-terminal
domain of CREB3L1 (CREB3L1[D381–519]), which enters the
nucleus without cleavage. Overexpression of CREB3L1(D381–
519) also inhibited HCV replication in Huh7-K2040 cells as
indicated by NS5A expression (Figure 2D). This effect was not
observed when the DNA-interacting bZIP domain (Figure 2A)
was deleted from the nuclear CREB3L1 (CREB3L1[D290–519])
(Figure 2E), even though deletion of this domain did not prevent
nuclear localization of the protein (Figure S2). These results
suggest that the nuclear CREB3L1 is likely to activate transcrip-
tion of genes that inhibit viral replication.
Nuclear CREB3L1 Blocks Cell Proliferation
To identify genes activated by CREB3L1, we transfected Huh7-
K2040 cells with CREB3L1(D381–519) subcloned into pTracer
and used FACS to isolate cells that expressed GFP and
CREB3L1. Microarray analysis was performed to compare
gene expression between these cells and cells transfected
with the empty pTracer plasmid. In addition to collagen 1a1,
a known target of CREB3L1 (Murakami et al., 2009),
CREB3L1(D381–519) also activated transcription of a group of
genes that inhibit the cell cycle (Table S2). These genes encode
cyclin inhibitors p21 and p18 (Sherr and Roberts, 1999), c-myc68 Cell Host & Microbe 10, 65–74, July 21, 2011 ª2011 Elsevier Inc.antagonists Mxi-1 (Hurlin and Huang, 2006), and other proteins
known to inhibit cell proliferation, such as GADD45g (Lieber-
mann and Hoffman, 2002), SPARC (Bradshaw and Sage,
2001), and RGC32 (Saigusa et al., 2007). Real-time QPCR anal-
ysis confirmed that all of these genes were induced by
CREB3L1(D381–519) (Figure 3A). Despite this induction, none
of the 50-flanking regions of these genes contains the nucleotide
sequences reported to bind CREB3L1 (Kondo et al., 2005; Mur-
akami et al., 2009). To identify the CREB3L1 response element in
these cell-cycle-inhibitory genes, we performed reporter assays
using a luciferase reporter gene driven by a 2 kb fragment of the
50-flanking region of p21. Luciferase activity was markedly
enhanced (20-fold) by CREB3L1(D381–519) transfected into
Huh7-K2040 cells (Figure 3B). Serial deletion analysis indicated
that a segment encompassing nucleotide positions 40 to
16 relative to the transcription start site of p21 conveyed
CREB3L1 inducibility (Figure 3B). Sequence analysis revealed
that position 34 to 26 within this fragment contains a
consensus sequence GTGXGCXGC that is conserved in pro-
moters of all genes activated by CREB3L1 (Figure 3C). Deletion
of this sequence or the changing of all nucleotides in the
sequence to adenines reduced the ability of CREB3L1 to stimu-
late luciferase activity (Figure 3D). An artificial promoter contain-
ing only the consensus sequence (repeated three times) was
activated by CREB3L1 (Figure 3D). Chromatin immunoprecipita-
tion (ChIP) assays revealed that FLAG-tagged CREB3L1(D381–
519) bound to thepromoter region of endogenousp21 (Figure 3E,
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Figure 4. Nuclear Form of CREB3L1 Inhibits Cell Proliferation
(A) Huh7-K2040 cells were seeded and transfected with the indicated plasmid as described in Figure 1D. Three days after the transfection, percentage of the cells
expressing GFP encoded by the transfected plasmid was determined through FACS analysis. Results are reported as mean ± SD (n = 3).
(B) On day zero, Huh7-K2040 cells were seeded at 2.53 105 per well of a 6-well plate. On day one, they were transfectedwith 0.25 mg of the indicated plasmid. On
day two, the cells were subjected to time-lapse imaging analysis as described in Experimental Procedures. On day four (48 hr later), GFP fluorescence images
were taken. Representative time-lapse images of these cells were shown, with arrows indicating transfected cells and their daughter cells determined by their
expression of GFP at the end of the imaging at 48 hr.
(C) Quantification of transfected cells that went through cell divisions in (B). On average, 30 cells transfected with each plasmid were counted in each experiment.
Results are reported as mean ± SD (n = 3).
Cell Host & Microbe
CREB3L1 Blocks Division of Virus-Infected Cellslane 6). Deletion of the bZIP domain from the NH2-terminal
segment of CREB3L1 (CREB3L1[D290–519]) abolished this
interaction (Figure 3E, lane 4).
The above results suggest that the nuclear form of CREB3L1
inhibits cell-cycle progression by binding to promoters and acti-
vating transcription of genes encoding cell-cycle inhibitors. To
test this hypothesis, we transfected Huh7-K2040 cells with
CREB3L1(D381–519) subcloned into pTracer, incubated the
cells for 3 days to allow these cells to divide, and quantified
the number of cells containing the plasmid by FACS. The number
of GFP-positive cells was 4-fold less in cells transfected with
pTracer-CREB3L1(D381–519) than those transfected with the
empty pTracer (Figure 4A), suggesting that CREB3L1(D381–
519) inhibited cell proliferation. This effect was not observed
when Huh7-K2040 cells were transfected with the nuclear
CREB3L1 in which bZIP domain is deleted (CREB3L1[D290–
519]) (Figure 4A).
To more directly access the role of CREB3L1 in cell prolifera-
tion, we performed time-lapse imaging analysis of Huh7-K2040Ccells transfected with the NH2-terminal fragment of CREB3L1
subcloned into pTracer. At the end of the experiment, GFP fluo-
rescent images were taken to identify cells transfected with the
plasmid, and these cells were traced backward to determine if
they underwent division events (Movies S1–S3). Representative
time-lapse images of Huh7-K2040 cells transfected with
pTracer-CREB3L1(D381–519), pTracer-CREB3L1(D290–519),
or the pTracer vector are shown in Figure 4B. Quantitative
analysis of these images indicated that more than 70% of cells
transfected with the empty pTracer went through at least one
cycle of cell division during a period of 48 hr (Figure 4C). Less
than 20% of cells transfected with pTracer-CREB3L1(D381–
519) divided during the same period (Figure 4C). Deletion of
the bZIP domain in CREB3L1 (CREB3L1(D290–519)) abolished
the inhibition of cell division (Figure 4C).
The data presented above indicate that HCV infection induces
the processing of CREB3L1 to its nuclear form, which in turn
suppresses cell-cycle progression by coordinately activating
a host of genes encoding proteins that inhibit the cell cycle.ell Host & Microbe 10, 65–74, July 21, 2011 ª2011 Elsevier Inc. 69
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Figure 5. RIP of CREB3L1 Inhibits Prolifera-
tion of Cells Infected by WNV
(A) Real-time QPCR quantification of CREB3L1
mRNA in indicated cells with the value in Huh7
cells set to 1. Results are reported as mean ± SD
(n = 3).
(B) Immunoblot analysis of CREB3L1 protein
precursor in indicated cells is shown.
(C) Proteolytic cleavage of CREB3L1 was ana-
lyzed as described in Figure 2B.
(D) On day zero, Huh7-K2040 and Huh7-WNV2
cells were seeded at 2 3 105/60 mm dish. On day
one, the cells were treated with or without 10 mM
hydroxyurea. On day five, cells were harvested for
quantification of HCV and WNV RNA in Huh7-
K2040 and Huh7-WNV2 cells, respectively, by
real-time QPCR, with the values in cells that were
not treated with the drug set to 1. Results are re-
ported as mean ± SD (n = 3).
(E) Quantification of Huh7-WNV2 cells trans-
fected with indicated plasmid that went through
cell divisions was carried out as described in
Figure 4C.
Cell Host & Microbe
CREB3L1 Blocks Division of Virus-Infected CellsInasmuch as active division of host cells is known to be required
for efficient HCV replication (Pietschmann et al., 2001; Scholle
et al., 2004), we conclude that the nuclear form of CREB3L1
suppresses HCV replication by blocking the cell cycle. In order
for cells to become permissive for HCV replication, CREB3L1
must be silenced, as in Huh7.5 and HRP-1 cells, so that these
cells are able to divide after they are infected by HCV.
CREB3L1 Blocks Proliferation of Cells Infected by
Viruses Other than HCV
To determine the role of CREB3L1 in defending viruses other
than HCV, we examined the expression of the gene in Huh7-
WNV2 cells, a line of a Huh7 cells harboring a replicon of WNV,
another flavivirus (Wang et al., 2005). We observed that expres-
sion of CREB3L1 is markedly reduced in these cells, compared
to the parental Huh7 cells, as determined by real-time QPCR
(Figure 5A) and immunoblot analysis (Figure 5B). CREB3L1
was cleaved to produce the nuclear form upon transfection
into Huh7-WNV2 but not Huh7 cells (Figure 5C). Unlike HCV,
replication of WNV was not affected by overexpression of the
nuclear form of CREB3L1 (data not shown). This result suggests
that unlike HCV, replication of WNV may not depend on active
division of host cells. To test this hypothesis, we incubated
Huh7 cells harboring an HCV or WNV replicon with hydroxyurea,
a drug that inhibits the cell cycle by blocking DNA synthesis (Ye
et al., 2003). While reducing the amount of HCV RNA, the drug
treatment did not affect the amount of WNV RNA (Figure 5D).
However, overexpression of the nuclear form of CREB3L1 still
led to suppression of cell division inHuh7-WNV2cells (Figure 5E).
This result might explain why CREB3L1 has to be silenced in
Huh7-WNV2 cells, as these cells have to proliferate in the pres-
ence of persistent replication of WNV genome.
To determine whether the effect of CREB3L1 is restricted to
flavivirus, we examined the role of CREB3L1 in inhibiting prolifer-
ation of cells infected by Sendai virus, a negative-stranded RNA70 Cell Host & Microbe 10, 65–74, July 21, 2011 ª2011 Elsevier Inc.virus of Paramyxoviridae. Infection of Huh7 cells with Sendai
virus stimulated the cleavage of CREB3L1 (Figure 6A). Infection
of Sendai virus almost completely blocked proliferation of Huh7
cells, which express CREB3L1 (Figure 6B). The proliferation of
HRP-1 cells, which do not express CREB3L1, was not affected
by the viral infection (Figure 6B). Huh7-shCREB3L1 cells, which
were generated by stably transfecting Huh7 cells with a shRNA
targeting CREB3L1, produced much less CREB3L1 mRNA (Fig-
ure S3A). Proliferation of these cells was also not affected by the
Sendai virus infection (Figure 6B). The failure of Sendai virus to
inhibit proliferation of HRP-1 and Huh7-shCREB3L1 cells was
not caused by less efficient infection of the cells by the virus,
as the amount of viral RNA in these cells was even more than
that in Huh7 cells (Figure 6C). Sendai virus did not lyse the cells
in the experiments as there was no lactate dehydrogenase
activity detected in the culture medium. Similar to WNV, replica-
tion of Sendai virus does not require proliferation of host cells, as
hydroxyurea treatment did not inhibit replication of the viral RNA
(Figure S3B).
To investigate the role of CREB3L1 in defending against infec-
tion of DNA virus, we infected Huh7 cells with murine g-herpes-
virus 68 (MHV-68). The genome of MHV-68 we used also
encodes GFP that serves as a marker for viral infection (Dong
et al., 2010). As with Sendai virus, infection of Huh7 cells with
MHV-68 also triggered the cleavage of CREB3L1 (Figure 6D).
Infection with MHV-68 blocked the proliferation of Huh7 cells
(Figure 6E). Proliferation of HRP-1 and Huh7-shCREB3L1 cells,
which express much less CREB3L1 compared to the parental
Huh7 cells, was not affected by the viral infection (Figure 6E).
The lack of CREB3L1 did not affect viral infection, as expression
of GFP encoded by MHV-68 was the same in Huh7, HRP-1, and
Huh7-shCREB3L1 cells (Figure 6F).
To determine the function of CREB3L1 in cells that are not
derived fromHuh7cells,we infectedSV589cells, an immortalized
line of human fibroblasts (Yamamoto et al., 1984), with Sendai
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Figure 6. CREB3L1 Prevents Proliferation of
Cells Infected by Sendai Virus and MHV-68
(A) On day zero, Huh7 cells were seeded at 4 3
105/60 mm dish. On day one, the cells were in-
fected with Sendai virus. On day two, the cells
were fractionated into nuclear and membrane
fractions, and the cleavage of CREB3L1 was
determined by immunoblot analysis with anti-
CREB3L1. (All panels) Bar graphs are reported as
mean ± SD (n = 3).
(B and C) On day zero, Huh7, HRP-1, and Huh7-
shCREB3L1 cells were seeded at 2 3 105/60 mm
dish. On day one, triplicate dishes of the cells
were harvested for cell counting. The remaining
cells were infected with Sendai virus as indicated.
On day two (24 hr later), triplicate dishes of
these cells were harvested and the number of cells
in each plate was quantified. The percentage
increase in cell number on day two versus that
on day one is presented (B). Sendai virus RNA
in the cells infected by the virus was quantified
by real-time QPCR with the value in Huh7 cells
set to 1 (C).
(D) Proteolytic cleavage of CREB3L1 was
analyzed as in (A), except that the cells were in-
fected by MHV-68 instead of Sendai virus.
(E and F) Indicated cells were seeded and treated
as described in (B), except that the cells were in-
fected by MHV-68 instead of Sendai virus. Prolif-
eration of the cells was determined as described in
(B). Cellular lysate was subjected to immunoblot
analysis with anti-GFP (F).
Cell Host & Microbe
CREB3L1 Blocks Division of Virus-Infected Cellsvirus. The viral infection stimulated the cleavage of CREB3L1 in
SV589 cells (Figure S3C). Sendai virus infection reduced the
rate of proliferation of SV589 cells transfected with the control
siRNA, but not those transfected with the siRNA targeting
CREB3L1 (FigureS3D),whichdecreased theamountofCREB3L1
mRNA by 90% (Figure S3E). Knockdown of CREB3L1 did not
alter the amount of viral RNA in SV589, suggesting that the failure
of Sendai virus to inhibit proliferation of SV589 cells in which
CREB3L1 was knocked down was not caused by less efficient
infection of the cells by the virus (Figure S3F).
DISCUSSION
The results presented above support a model shown in Figure 7.
CREB3L1 is synthesized as a membrane-bound precursor. In
cells infected by aDNAvirus such asMHV-68, negative-stranded
RNA viruses such as Sendai virus, or positive-stranded RNA
viruses such as HCV and WNV, CREB3L1 is activated by RIP
catalyzedbyS1PandS2P.Asananalogy tootherwell-character-
ized transcription factors activated through RIP, we assume that
the viral infection stimulates the translocation of CREB3L1
precursor from the ER to the Golgi complex in which S1P and
S2P reside (DeBose-Boyd et al., 1999; Shen et al., 2002).
Following the cleavage, the NH2-terminal domain of CREB3L1
enters the nucleus, where it activates transcription of genes en-
coding cell-cycle inhibitors to block proliferation of the virus-in-
fected cells. For most of the viruses we analyzed, inhibition ofCproliferation of their host cells did not affect their replication.
Thus, rather than directly inhibiting viral replication, CREB3L1
may play an important role in preventing virus spread by limiting
proliferation of virus-infected cells. Among the viruses we
studied, HCV is unique in that its replication in Huh7-derived cells
requires active division of the host cells (Pietschmannet al., 2001;
Scholle et al., 2004). As a result, CREB3L1-mediated signaling
not only blocks proliferation of virus-infected cells, but also
inhibits HCV replication. However, the in vivo relevance of the
observation remains to be determined. Although hepatocytes
do not enter the cell cycle in healthy livers, they proliferate rapidly
to repair liver injuries induced by HCV infection. Thus, further
studies are required to determinewhether CREB3L1 inhibits divi-
sion of virus-infected hepatocytes in vivo to limit HCV replication
at a low level and to prevent the spread of the virus.
It was reported previously that ER stress triggers cleavage of
CREB3L1 (Murakami et al., 2006). ER stress is also known to
be induced by massive synthesis of ER-associated viral proteins
in cells infectedbyviruses (He, 2006). Theseviruses include those
used in the current study, such as HCV (Tardif et al., 2002; von
dem Bussche et al., 2010) and WNV (Medigeshi et al., 2007).
Thus, it is conceivable that viral infection triggers cleavage
of CREB3L1 through ER stress. If this is the case, CREB3L1
may belong to a growing list of proteins that defend against viral
infection through ER stress (Martinon and Glimcher, 2011).
In the current study, we show that both Huh7.5 and HRP-1
cells are highly permissive for replication of HCV subgenomicell Host & Microbe 10, 65–74, July 21, 2011 ª2011 Elsevier Inc. 71
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Figure 7. A Model Illustrating the Role of
CREB3L1 in Limiting Proliferation of Virus-
Infected Cells
CREB3L1 is synthesized as a membrane-bound
precursor. In cells infected by virus, CREB3L1 is
activated through RIP, presumably through ER
stress caused by expression of ER-associated
viral proteins. The proteolytic cleavage allows the
NH2-terminal domain of the protein to enter the
nucleus, where it activates transcription of genes
encoding cell-cycle inhibitors to block proliferation
of the cells infected by the virus.
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CREB3L1 Blocks Division of Virus-Infected Cellsreplicons derived from the genotype 1 HCV, owing to the lack of
expression of CREB3L1. However, only Huh7.5 but not HRP-1
cells can be infected by the JFH1 strain of the genotype 2
HCV. Unlike genotype 1 HCV, genotype 2 HCV is much more
sensitive to interferon (Zein, 2000). This difference between
Huh7.5 and HRP-1 cells might be explained by a mutation in
RIG-I found in Huh7.5 (Sumpter et al., 2005), but not in HRP-1
cells, which makes Huh7.5 but not HRP-1 cells defective in
producing interferon in response to viral infection.
Inasmuch as CREB3L1 inhibits cell proliferation by activating
genes encoding proteins that inhibit the cell cycle, it may be
considered as a tumor suppressor gene. Indeed, inactivation
of CREB3L1 through chromosome fusion is associated with
development of low-grade fibromyxoid sarcoma (Mertens
et al., 2005). Considering that CREB3L1 is proteolytically acti-
vated in virus-infected cells, the protein may play an important
role in preventing virus-induced tumorigenesis. Notably, the
ability of CREB3L1 to inhibit cell proliferation has not been
observed in previous studies that analyze genes activated by
the protein (Kondo et al., 2005; Murakami et al., 2009; Vellanki
et al., 2010; Fox et al., 2010). Unlike the current study, these anal-
yses were not performed in virus-infected cells. We observed
that the nuclear form of CREB3L1 activated genes that suppress
cell proliferation muchmore profoundly in Huh7-K2040 cells that
harbor an HCV replicon than the naive Huh7 cells (data not
shown). Thus, it is likely that another factor generated in virus-
infected cells cooperates with the nuclear form of CREB3L1 to
activate these genes.
In addition to genes encoding proteins that inhibit the
cell cycle, CREB3L1 also activates transcription of type 1
collagen and genes involved in assembly of collagen matrix as
previously reported (Murakami et al., 2009; Vellanki et al.,
2010). This observation suggests that in addition to preventing
proliferation of virus-infected cells, CREB3L1 may also limit the
spread of the virus by activating production of small amounts
of collagen in virus-infected cells to segregate these cells from72 Cell Host & Microbe 10, 65–74, July 21, 2011 ª2011 Elsevier Inc.their environment. Further study will be
required to determine whether chronic
deposition of collagen produced in
virus-infected cells contributes to fibrosis
induced by viral infection.
EXPERIMENTAL PROCEDURES
Antibodies
We obtained rabbit anti-actin and anti-GFP
from Abcam; mouse anti-HSV from Novagen;rabbit anti-LSD1 from Cell Signaling; mouse anti-calnexin from Enzo Life
Sciences; peroxidase-conjugated secondary antibodies from Jackson
ImmunoResearch. Rabbit anti-NS5A was described previously (Huang et al.,
2007). A rabbit polyclonal antibody against human CREB3L1 was generated
by immunizing rabbits with a protein consisting of the NH2-terminal 290 amino
acid residues of human CREB3L1.
Cell Culture
Huh7, Huh7.5, HRP-1, and SV589 cells were maintained in medium A (Dul-
becco’s modified Eagle’s medium with 4.5 g/l glucose, 100 U/ml penicillin,
100 mg/ml streptomycin sulfate, and 10% fetal calf serum). Huh7-K2040 cells
were maintained in medium A supplemented with 200 mg/ml G418. Huh7-GL
cells, a line of Huh7 cells that contain a chromosomally integrated JFH strain
of HCV cDNA and constitutively produce infectious virus (Cai et al., 2005),
were maintained in medium A supplemented with 5 mg/ml blasticidine.
Huh7-shCREB3L1 cells were generated by stably transfecting a shRNA
targeting CREB3L1 (SA Biosciences, Clone ID 2) into Huh7 cells. The cells
were maintained in medium A supplemented with 10 mg/ml puromycin. All
cells were cultured in monolayers at 37C in 5% CO2.
Plasmids
pTracer-CMV (Invitrogen) is a plasmid that allows detection of transfected
cells through expression of GFP encoded by the plasmid. pTracer-CREB3L1,
pTracer-CREB3L1(D381–519), and pTracer-CREB3L1(D290–519) encode
CREB3L1 and its deletion mutants. pTK-HSV-CREB3L1 encodes full-length
CREB3L1 preceded by two copies of the HSV epitope tag (QPELAPEDPED)
at the NH2-terminus under the control of the TK promoter. pTK-HSV-
CREB3L1(R423A) and pTK-HSV-CREB3L1(P392A/P395A) were generated
using the QuikChange II XL Site-Directed Mutagenesis Kit (Stratagene) with
pTK-HSV-CREB3L1 as the template. pCMV-CREB3L1(D381–519) encodes
a deletion mutant of CREB3L1 under the control of the CMV promoter.
pCMV-FLAG-CREB3L1(D290–519) and pCMV-FLAG-CREB3L1(D381–519)
encodes deletion mutants of CREB3L1 preceded with a FLAG epitope tag
(DYKDDDDK) under control of a CMV promoter. For luciferase reporter exper-
iments shown in Figures 3B and 3D, indicated regions of p21 promoter were
cloned into pGL3 vector (Genescript).
Real-Time QPCR
Real-time QPCRwas performed as previously described (Ye et al., 2003; Liang
et al., 2002). Briefly, total RNA prepared from cells was treated extensively with
DNase I (DNA-free, Ambion, Austin, TX). First-strand cDNA was synthesized
from the DNA-free RNA by using random hexamer primers and the ABI
Cell Host & Microbe
CREB3L1 Blocks Division of Virus-Infected CellscDNA synthesis kit (Applied Biosystems). cDNA was mixed with SYBR Green
PCRMaster Mix (Applied Biosystems) and sets of forward and reverse primers
specific for the RNA subjected to the measurement and analyzed by real-time
QPCR with the ABI PRISM 7900HT sequence detection system (Applied
Biosystems). All reactions were performed in triplicate. The relative amounts
of RNAs were calculated through the comparative cycle threshold method
by using human 36B4 mRNA as the invariant control.
Virus Infection
The JFH1 strain of HCV was produced from Huh7-GL cells, a gift from Guang-
xiang Luo (University of Kentucky), as previously described (Huang et al.,
2007). The HCVHP or con1 replicon RNAwas in vitro transcribed as previously
described (Sumpter et al., 2004) and transfected into Huh7 cells using Trans-
Messenger Reagent (QIAGEN). Sendai virus (Cantell strain) was purchased
from Charles River Laboratories. The virus was added to cells after it was
diluted 50-fold in cell-culture medium (3 ml/60 mm plate). MHV-68, a gift
from Pinghui Feng (University of Texas Southwestern Medical Center), was
used to infect the cells with amultiplicity of infection of 2 through spin infection,
by spinning the cells at 1000 g for 30 min.
RNA Interference
Duplexes of siRNAwere synthesized by Dharmacon Research. The two siRNA
sequences targeting human CREB3L1 (NCBI Accession number NM_052854)
are at nucleotide positions (relative to the codon for the initiation methionine)
131–149 and 884–902, for CREB3L1-1 and CREB3L1-2, respectively. The
control siRNA targeting GFP was reported previously (Adams et al., 2004).
Cells were transfected with siRNA using Lipofectamine RNAiMAX reagent
(Invitrogen) as described by the manufacturer, after which the cells were
used for experiments as described in the figure legends.
Immunoblot Analyses to Determine RIP of CREB3L1
Cells were harvested and separated into nuclear and membrane fractions as
described (Sakai et al., 1996). Four mg of nuclear fractions and 10 mg of
membrane fractions were analyzed by 10% SDS-PAGE followed by immuno-
blot analysis with anti-HSV (0.25 mg/ml). Bound antibodies were visualized
with a peroxidase-conjugated secondary antibody using the SuperSignal
ECL-HRP substrate system (Pierce).
Isolation of Transfected Cells through FACS
Cells were trypsinized and sorted on a BD FACSAria Flow Cytometer (Becton
Dickinson) based on expression of GFP by the University of Texas South-
western Flow Cytometry Core Facility. Sorted cells with or without GFP
expression were then used for assays described in figure legends.
Luciferase Assays
Luciferase activity in the cell lysate was assayed with the Dual-Luciferase
Reporter Assay system (Promega) using the Synergy 4 plate reader and
Gen5 1.10 software (Biotek). Promoter activity was determined by firefly lucif-
erase activity normalized against Renilla luciferase activity to control for trans-
fection efficiency.
ChIP Analyses
ChIP was performed using the SimpleChiP Enzymatic Chromatin IP Kit (Cell
Signaling Technology) according to the manufacturer’s protocol. Genomic
DNA was used for PCR with the AccuPrime Pfx Supermix Kit (Invitrogen) using
primers 50-AACTCGGCCAGGCTCAGCTG-30 and 50-GCTCCACAAGGAACT
GACTTCGGCAG-30 to amplify a 200 bp segment of the p21 promoter. PCR
products were run on a 2% agarose gel and imaged with the Eagle Eye II gel
documentation system with EagleSight Software (Stratagene).
Time-Lapse Imaging
Cells were changed into CO2-Independent Medium (Invitrogen) supplemented
with 10% FCS, 1% penicillin/streptomycin, 2 mM GlutaMAX (Invitrogen), and
1 mM sodium pyruvate for the imaging analysis. Phase contrast time-lapse
imaging was performed with an Axiovert 200M (Ziess) microscope in a 37C
chamber, and images were taken every 10 minutes for 48 hr in at least four
different fields per well using MetaMorph Software (Molecular Devices). GFP
fluorescence images were taken at the end of the experiment at 48 hr. CellsCtransfected with different plasmids were imaged in parallel using a motorized
stage (Marzhauser). Cells expressing GFP at 48 hr were traced backward to
determine if these cells underwent division events.
Microarray Analysis
Microarray analysis was performed exactly as previously described (Horton
et al., 2003).
ACCESSION NUMBERS
Microarray data were deposited at Gene Expression Omnibus (GEO). Microar-
ray analyses comparing gene expression between Huh7 versus Huh7.5 and
HRP-1 cells as well as Huh7-K2040 cells transfected with CREB3L1(D381–
519) versus thosemock-transfected can be found with the accession numbers
GSE25156 and GSE25157, respectively.
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